Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.
Press releases published on April 13, 2026
Apr. 13, 2026
Seacoast AI Uses Leverage’s Sovereign AI to Put Its Data to Work
Indeterminate
EIN Presswire
Apr. 13, 2026
Town of Millbury Partners with PlanetBids to Modernize and Streamline Procurement Processes
Indeterminate
EIN Presswire
Apr. 13, 2026
G6 Hospitality to Convene Its Largest Franchise Conference in Cancún
Indeterminate
GlobeNewswire
Apr. 13, 2026
Boston Pads Database Surpasses 300,000 Units, Expanding Footprint Beyond Greater Boston
Indeterminate
EIN Presswire
Apr. 13, 2026
Biomerica Reports Third Quarter Fiscal 2026 Financial Results
Indeterminate
GlobeNewswire
Apr. 13, 2026
Dash Social Brings Canva Into Its Platform, Connecting Design, Data, and Publishing for Social Teams
Indeterminate
GlobeNewswire
Apr. 13, 2026
AIM ImmunoTech Provides Routine Update on Annual Filings
Indeterminate
GlobeNewswire
Apr. 13, 2026
CEA Industries Stapled Warrants to Begin Trading on Nasdaq Capital Market
Indeterminate
GlobeNewswire
Apr. 13, 2026
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset
Indeterminate
GlobeNewswire
Apr. 13, 2026
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock
Indeterminate
GlobeNewswire
Apr. 13, 2026
BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference
Indeterminate
GlobeNewswire
Apr. 13, 2026
Datacentrex Reports Full Year 2025 Results; Achieves Positive Adjusted EBITDA in Transformational Year
Indeterminate
GlobeNewswire
Apr. 13, 2026
Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform
Indeterminate
GlobeNewswire
Apr. 13, 2026
Rezolve Ai to Host Investor Call: The $700M+ Case for Combining with Commerce.com
Indeterminate
GlobeNewswire
Apr. 13, 2026
Varonis Announces Date of First Quarter 2026 Financial Results
Indeterminate
GlobeNewswire
Apr. 13, 2026
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire